SLC5A2 and cardiovascular disorder: PDC: proportion of days covered; BMI: body mass index; O-SEMA: oral semaglutide; SEMA-SC: once-weekly semaglutide subcutaneous injection; α-GI: alpha-glucosidase inhibitor; SGLT2is: sodium-glucose cotransporter 2 inhibitors; CVD: cardiovascular diseases